As such, the WHO has recommended that countries with PfHRP2/3 deletions and neighboring countries should “conduct baseline surveys among suspected malaria cases” to determine whether there is a greater than 5% HRP2 deletion rate resulting in false negatives [2]. The gene discussed is HDGFL2; the disease is malaria.